
Chief operating officer appointed to Clinigen’s services division
pharmafile | January 19, 2012 | Appointment | Business Services, Medical Communications, Research and Development, Sales and Marketing | Clinigen, Shaun Chilton
Clinigen Group, a global specialty pharma services and products business, has appointed Shaun Chilton as its new chief operating officer of the group’s services division.
In this newly-created role, Chilton will have overall leadership responsibility for the division, incorporating two of Clinigen’s operations.
This includes Keats Healthcare, a clinical trial supply business (being re-branded as Clinigen CTS), and Clinigen GAP, a provider of early- and late-lifecycle prescription drugs.
Chilton, who will report to Clinigen Group’s chief executive, Peter George, has 20 years’ commercial, strategic and operational experience.
He joins Clinigen from KnowledgePoint360 Group, a global healthcare information and services provider, where he was president and managing director.
Before joining KnowledgePoint360, Chilton was global VP of medical communications at Wolters Kluwer Health, Pharma Solutions.
He began his professional career in sales and marketing roles for Pfizer and Sanofi-Aventis.
Related Content

Clinigen becomes sole license holder of cancer drug Proleukin in $210m deal
Novartis has arranged to sell the remainder of its rights to its skin and lung …

Clinigen shares soar after $210m Novartis cancer drug deal
British company Clinigen has bought the rights to sell Novartis’ cancer drug Proleukin in the …

Eisai & Clinigen to bring breast cancer drug to South Africa
Eisai and Clinigen have formed a collaboration to deliver the former’s cancer treatment Halaven (eribulin) …






